【標靶】《Molecure: MOC》與《Avicenna》攜手開發「蛋白酶 7」的新型小分子藥物

 【標靶】《Molecure: MOC》與《Avicenna Bio》攜手開發「蛋白酶 7 (USP7)」的新型小分子藥物

 文章出處  

Businesswire 

 

 原文標題  

Avicenna Biosciences and Molecure S.A. Sign Strategic Research Collaboration Agreement to Accelerate Discovery and Development of Small Molecule Drugs 

 

 Twitter  

https://x.com/aimedadviser/status/1819158241060049004 

 

 文章序號  

6028 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2024 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.